AnkurRasikParikhDO

Oncology • Willow Grove, PA

Gastrointestinal Cancer

Associate Medical Director, Precision Medicine

Join to view full profile

Dr. Parikh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Parikh's full profile

Already have an account?

Office
Asplundh Cancer Pavilion
3941 Commerce Ave
Willow Grove, PA 19090

Summary

I am a medical oncologist and associate medical director of precision medicine. I believe that genomic based therapy and immuno-oncology are rapidly changing the landscape of cancer treatment. I am involved with clinical research and enjoy speaking at national conferences and seminars on the topics of precision medicine and oncology.

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
OhioHealth/Riverside Methodist HospitalResidency, Internal Medicine, 2006 - 2009
A. T. Still University Kirksville College of Osteopathic MedicineClass of 2006

Certifications & Licensure

PA State License 2012 - 2024
MD State License 2009 - 2013
OH State License 2006 - 2009
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome Start of enrollment: 2005 Jul 21
Completed
Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer Start of enrollment: 2016 Mar 14
Recruiting
Phase 2
Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer Start of enrollment: 2017 Mar 01
Completed
Phase 3

Publications & Presentations

PubMed

14 citations
Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations.
K Murugesan, A Necchi, T C Burn, O Gjoerup, R Greenstein
ESMO Open. 2022-12-01
2 citations
Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome.
Alana Vicente, Bhavisha A Patel, Fernanda Gutierrez-Rodrigues, Emma Groarke, Valentina Giudice
Haematologica. 2020-12-01
16 citations
Lung Cancer Genomics.
Ankur R. Parikh
Acta Medica Academica. 2019-06-26

Journal Articles

Applying Genomics to Leukemias & Lymphomas
Parikh AR, Oncology Times, 9/5/2018
Under representation of Elderly Population in Clinical Trials
Parikh AR, Oncology Times, 7/5/2018
A Look at Cancer Immunotherapy in Elderly Patients
Parikh AR, Oncology Times, 4/20/2018

Abstracts/Posters

Detection of Targetable Kinase Fusions in 7260 patients in an integrated Cancer System
Parikh AR, et al., European Society for Medical Oncology 2018 Congress, Munich, Germany, 10/20/2018

Authored Content

We need more answers about immunotherapy for elderly6/22/2018

Press Mentions

How to Access Cutting-Edge Cancer Treatments and Clinical Trials in PhillyOctober 31st, 2020
FDA Approves Foundation Medicine’s Genetic Diagnostic Test as CMS Paves the Way for CoverageDecember 1st, 2017

Professional Memberships

American Society of Hematology - ASH
Member
American Society of Clinical Oncology - ASCO
Member
American Osteopathic Association - AOA
Member

External Links

LinkedInhttp://linkedin.com/in/ankur-parikh-646749141